High fish oil diet promotes liver inflammation and activates the complement system

Jin,Huimin; Yan,Cheng; Xiao,Tengfei; Yan,Nannan; Xu,Jie; Zhou,Liping; Zhou,Xiaoming; Shao,Qixiang; Xia,Sheng

doi:10.3892/mmr.2018.8687

High fish oil diet promotes liver inflammation and activates the complement system

Authors:
- Huimin Jin
- Cheng Yan
- Tengfei Xiao
- Nannan Yan
- Jie Xu
- Liping Zhou
- Xiaoming Zhou
- Qixiang Shao
- Sheng Xia
View Affiliations

Affiliations: Department of Immunology, School of Medicine, Jiangsu University, Zhenjiang, Jiangsu 212013, P.R. China, Department of Molecular Biology, School of Medicine, Jiangsu University, Zhenjiang, Jiangsu 212013, P.R. China, Department of Pathology, School of Medicine, Jiangsu University, Zhenjiang, Jiangsu 212013, P.R. China
Published online on: March 6, 2018 https://doi.org/10.3892/mmr.2018.8687
Pages: 6852-6858

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Diets rich in n-3 polyunsaturated fatty acid (n-3 PUFA) fish oil (FO) have beneficial effects in obesity‑associated metabolic disease. However, contradictory roles in inflammatory disease intervention have been reported. Our previous work revealed that a high‑FO diet promoted myeloid cell differentiation by modifying the bone marrow microenvironment; however, its effects on liver inflammation and complement system activation remain unknown. By performing ELISA, reverse transcription‑quantitative polymerase chain reaction, flow cytometry and histology on mice fed with high‑FO and low‑fat diets, the present study demonstrated that a 4‑week high‑FO diet promoted liver inflammation in mice without affecting body or liver weight. The livers of high‑FO diet mice exhibited increased infiltration of T cells and CD11b+ Gr‑1+ myeloid cells. Additionally, a higher level of IL‑1β and MCP‑1 mRNA expression was detected, suggesting that the high‑FO diet promoted liver inflammation. Further experiments indicated that the high‑FO diet increased the total hemolytic complement activity (CH50), promoted the production of the membrane attack complex and increased the levels of various complement proteins in vivo, including complement components C3, C4b, C1qb and factor B. Furthermore, higher concentrations of triglyceride were detected in the peripheral blood of high‑FO diet mice, indicating the potential protective roles of n‑3 PUFAs in FO against lipotoxicity in hyperlipidemia. Collectively, the present study demonstrated that high FO intake induced inflammation and activated the complement system in the liver. However, further study is required to determine the exact mechanisms.

View Figures

View References

1	Banchereau J and Steinman RM: Dendritic cells and the control of immunity. Nature. 392:245–252. 1998. View Article : Google Scholar : PubMed/NCBI
2	Austyn JM: Death, destruction, danger and dendritic cells. Nat Med. 5:1232–1233. 1999. View Article : Google Scholar : PubMed/NCBI
3	Iwasaki A and Medzhitov R: Regulation of adaptive immunity by the innate immune system. Science. 327:291–295. 2010. View Article : Google Scholar : PubMed/NCBI
4	Cruvinel Wde M, Mesquita D Jr, Araújo JA, Catelan TT, de Souza AW, da Silva NP and Andrade LE: Immune system-part I. Fundamentals of innate immunity with emphasis on molecular and cellular mechanisms of inflammatory response. Rev Bras Reumatol. 50:434–461. 2010.(In English, Portuguese). View Article : Google Scholar : PubMed/NCBI
5	Walport MJ: Complement. First of two parts. N Engl J Med. 344:1058–1066. 2001. View Article : Google Scholar : PubMed/NCBI
6	Arbore G, West EE, Spolski R, Robertson AAB, Klos A, Rheinheimer C, Dutow P, Woodruff TM, Yu ZX, O'Neill LA, et al: T helper 1 immunity requires complement-driven NLRP3 inflammasome activity in CD4⁺ T cells. Science. 352:aad12102016. View Article : Google Scholar : PubMed/NCBI
7	Cravedi P, van der Touw W and Heeger PS: Complement regulation of T-cell alloimmunity. Semin Nephrol. 33:565–574. 2013. View Article : Google Scholar : PubMed/NCBI
8	Martin M and Blom AM: Complement in removal of the dead-balancing inflammation. Immunol Rev. 274:218–232. 2016. View Article : Google Scholar : PubMed/NCBI
9	Ricklin D, Hajishengallis G, Yang K and Lambris JD: Complement: A key system for immune surveillance and homeostasis. Nat Immunol. 11:785–797. 2010. View Article : Google Scholar : PubMed/NCBI
10	Suresh R, Chandrasekaran P, Sutterwala FS and Mosser DM: Complement-mediated ‘bystander’ damage initiates host NLRP3 inflammasome activation. J Cell Sci. 129:1928–1939. 2016. View Article : Google Scholar : PubMed/NCBI
11	Liu HQ, Qiu Y, Mu Y, Zhang XJ, Liu L, Hou XH, Zhang L, Xu XN, Ji AL, Cao R, et al: A high ratio of dietary n-3/n-6 polyunsaturated fatty acids improves obesity-linked inflammation and insulin resistance through suppressing activation of TLR4 in SD rats. Nutr Res. 33:849–858. 2013. View Article : Google Scholar : PubMed/NCBI
12	Serini S, Piccioni E, Merendino N and Calviello G: Dietary polyunsaturated fatty acids as inducers of apoptosis: Implications for cancer. Apoptosis. 14:135–152. 2009. View Article : Google Scholar : PubMed/NCBI
13	Shoelson SE, Lee J and Goldfine AB: Inflammation and insulin resistance. J Clin Invest. 116:1793–1801. 2006. View Article : Google Scholar : PubMed/NCBI
14	Kalupahana NS, Claycombe KJ and Moustaid-Moussa N: (n-3) Fatty acids alleviate adipose tissue inflammation and insulin resistance: Mechanistic insights. Adv Nutr. 2:304–316. 2011. View Article : Google Scholar : PubMed/NCBI
15	Cooke AA, Connaughton RM, Lyons CL, McMorrow AM and Roche HM: Fatty acids and chronic low grade inflammation associated with obesity and the metabolic syndrome. Eur J Pharmacol. 785:207–214. 2016. View Article : Google Scholar : PubMed/NCBI
16	Vlaicu SI, Tatomir A, Boodhoo D, Vesa S, Mircea PA and Rus H: The role of complement system in adipose tissue-related inflammation. Immunol Res. 64:653–664. 2016. View Article : Google Scholar : PubMed/NCBI
17	Lim J, Iyer A, Suen JY, Seow V, Reid RC, Brown L and Fairlie DP: C5aR and C3aR antagonists each inhibit diet-induced obesity, metabolic dysfunction and adipocyte and macrophage signaling. FASEB J. 27:822–831. 2013. View Article : Google Scholar : PubMed/NCBI
18	Hillian AD, McMullen MR, Sebastian BM, Roychowdhury S, Kashyap SR, Schauer PR, Kirwan JP, Feldstein AE and Nagy LE: Mice lacking C1q are protected from high fat diet-induced hepatic insulin resistance and impaired glucose homeostasis. J Biol Chem. 288:22565–22575. 2013. View Article : Google Scholar : PubMed/NCBI
19	Bavia L, Cogliati B, Dettoni JB, Ferreira Alves VA and Isaac L: The complement component C5 promotes liver steatosis and inflammation in murine non-alcoholic liver disease model. Immunol Lett. 177:53–61. 2016. View Article : Google Scholar : PubMed/NCBI
20	Alvarez-Curto E and Milligan G: Metabolism meets immunity: The role of free fatty acid receptors in the immune system. Biochem Pharmacol. 114:3–13. 2016. View Article : Google Scholar : PubMed/NCBI
21	Viggiano E, Mollica MP, Lionetti L, Cavaliere G, Trinchese G, De Filippo C, Chieffi S, Gaita M, Barletta A, De Luca B, et al: Effects of an high-fat diet enriched in lard or in fish oil on the hypothalamic amp-activated protein kinase and inflammatory mediators. Front Cell Neurosci. 10:1502016. View Article : Google Scholar : PubMed/NCBI
22	Poreba M, Mostowik M, Siniarski A, Golebiowska-Wiatrak R, Malinowski KP, Haberka M, Konduracka E, Nessler J, Undas A and Gajos G: Treatment with high-dose n-3 PUFAs has no effect on platelet function, coagulation, metabolic status or inflammation in patients with atherosclerosis and type 2 diabetes. Cardiovasc Diabetol. 16:502017. View Article : Google Scholar : PubMed/NCBI
23	Kremer JM: Fish oil and inflammation-A fresh look. J Rheumatol. 44:713–716. 2017. View Article : Google Scholar : PubMed/NCBI
24	Xia S, Li X, Cheng L, Han M, Zhang M, Liu X, Xu H, Zhang M, Shao Q and Qi L: Chronic intake of high fish oil diet induces myeloid-derived suppressor cells to promote tumor growth. Cancer Immunol Immunother. 63:663–673. 2014. View Article : Google Scholar : PubMed/NCBI
25	Xia S, Li XP, Cheng L, Han MT, Zhang MM, Shao QX, Xu HX and Qi L: Fish oil-rich diet promotes hematopoiesis and alters hematopoietic niche. Endocrinology. 156:2821–2830. 2015. View Article : Google Scholar : PubMed/NCBI
26	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
27	Xia S, Guo Z, Xu X, Yi H, Wang Q and Cao X: Hepatic microenvironment programs hematopoietic progenitor differentiation into regulatory dendritic cells, maintaining liver tolerance. Blood. 112:3175–3185. 2008. View Article : Google Scholar : PubMed/NCBI
28	Xia S, Sha H, Yang L, Ji Y, Ostrand-Rosenberg S and Qi L: Gr-1+ CD11b+ myeloid-derived suppressor cells suppress inflammation and promote insulin sensitivity in obesity. J Biol Chem. 286:23591–23599. 2011. View Article : Google Scholar : PubMed/NCBI
29	Gao B, Jeong WI and Tian Z: Liver: An organ with predominant innate immunity. Hepatology. 47:729–736. 2008. View Article : Google Scholar : PubMed/NCBI
30	Ricklin D, Reis ES, Mastellos DC, Gros P and Lambris JD: Complement component C3-The ‘Swiss Army Knife’ of innate immunity and host defense. Immunol Rev. 274:33–58. 2016. View Article : Google Scholar : PubMed/NCBI
31	Morgan BP and Gasque P: Extrahepatic complement biosynthesis: Where, when and why? Clin Exp Immunol. 107:1–7. 1997. View Article : Google Scholar : PubMed/NCBI
32	Marsh JE, Zhou W and Sacks SH: Local tissue complement synthesis-fine tuning a blunt instrument. Arch Immunol Ther Exp (Warsz). 49 Suppl 1:S41–S46. 2001.PubMed/NCBI
33	Alper CA, Johnson AM, Birtch AG and Moore FD: Human C′3: Evidence for the liver as the primary site of synthesis. Science. 163:286–288. 1969. View Article : Google Scholar : PubMed/NCBI
34	Morris KM, Aden DP, Knowles BB and Colten HR: Complement biosynthesis by the human hepatoma-derived cell line HepG2. J Clin Invest. 70:906–913. 1982. View Article : Google Scholar : PubMed/NCBI
35	Walport MJ: Complement. Second of two parts. N Engl J Med. 344:1140–1144. 2001. View Article : Google Scholar : PubMed/NCBI
36	Arlaud GJ, Biro A and Ling WL: Enzymatically modified low-density lipoprotein is recognized by c1q and activates the classical complement pathway. J Lipids. 2011:3760922011. View Article : Google Scholar : PubMed/NCBI
37	Arbore G and Kemper C: A novel ‘complement-metabolism-inflammasome axis’ as a key regulator of immune cell effector function. Eur J Immunol. 46:1563–1573. 2016. View Article : Google Scholar : PubMed/NCBI
38	Samstad EO, Niyonzima N, Nymo S, Aune MH, Ryan L, Bakke SS, Lappegård KT, Brekke OL, Lambris JD, Damås JK, et al: Cholesterol crystals induce complement-dependent inflammasome activation and cytokine release. J Immunol. 192:2837–2845. 2014. View Article : Google Scholar : PubMed/NCBI
39	Haeffner-Cavaillon N, Cavaillon JM, Laude M and Kazatchkine MD: C3a(C3adesArg) induces production and release of interleukin 1 by cultured human monocytes. J Immunol. 139:794–799. 1987.PubMed/NCBI
40	Bavia L, de Castro IA, Cogliati B, Dettoni JB, Alves VA and Isaac L: Complement C5 controls liver lipid profile, promotes liver homeostasis and inflammation in C57BL/6 genetic background. Immunobiology. 221:822–832. 2016. View Article : Google Scholar : PubMed/NCBI
41	Listenberger LL, Han X, Lewis SE, Cases S, Farese RV Jr, Ory DS and Schaffer JE: Triglyceride accumulation protects against fatty acid-induced lipotoxicity. Proc Natl Acad Sci USA. 100:pp. 3077–3082. 2003; View Article : Google Scholar : PubMed/NCBI